2,598 Shares in Omega Healthcare Investors, Inc. $OHI Bought by Trust Co. of Vermont

Trust Co. of Vermont bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,598 shares of the real estate investment trust’s stock, valued at approximately $95,000.

Several other large investors also recently made changes to their positions in the stock. GAMMA Investing LLC lifted its holdings in Omega Healthcare Investors by 4,248.2% in the 1st quarter. GAMMA Investing LLC now owns 174,102 shares of the real estate investment trust’s stock worth $6,630,000 after purchasing an additional 170,098 shares during the last quarter. Rhumbline Advisers raised its position in shares of Omega Healthcare Investors by 2.7% in the first quarter. Rhumbline Advisers now owns 797,469 shares of the real estate investment trust’s stock valued at $30,368,000 after purchasing an additional 20,710 shares during the period. NBC Securities Inc. acquired a new stake in shares of Omega Healthcare Investors in the first quarter worth $29,000. Merit Financial Group LLC boosted its holdings in shares of Omega Healthcare Investors by 27.9% during the 1st quarter. Merit Financial Group LLC now owns 43,594 shares of the real estate investment trust’s stock worth $1,660,000 after buying an additional 9,519 shares during the period. Finally, RFG Advisory LLC bought a new stake in shares of Omega Healthcare Investors during the 1st quarter worth $1,161,000. Institutional investors own 65.25% of the company’s stock.

Insiders Place Their Bets

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Mizuho raised their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a report on Thursday, September 11th. Royal Bank Of Canada lifted their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a “sector perform” rating in a research report on Thursday, August 7th. Cantor Fitzgerald initiated coverage on Omega Healthcare Investors in a research report on Wednesday. They issued an “overweight” rating and a $50.00 price objective for the company. Finally, Truist Financial boosted their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research report on Wednesday, September 3rd. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus price target of $44.44.

Omega Healthcare Investors Stock Performance

Shares of NYSE OHI opened at $41.60 on Friday. The firm has a market capitalization of $12.27 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 2.22 and a beta of 0.70. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42. The business has a fifty day simple moving average of $41.38 and a 200 day simple moving average of $38.68. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million for the quarter, compared to analyst estimates of $248.49 million. During the same quarter in the previous year, the firm posted $0.71 EPS. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.4%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.